Lind Global Fund II LP 13D/13G Filings for SEELOS THERAPEUTICS INC PA (SEELQ)

Lind Global Fund II LP 13D and 13G filings for SEELOS THERAPEUTICS INC PA:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-14
5:12 pm
Sale
2024-12-31 13G SEELOS THERAPEUTICS INC PA
SEELQ
Lind Global Fund II LP 0
0.000%
-44,500decrease
(Position Closed)
Filing
2024-11-14
7:32 pm
Purchase
2024-09-30 13G SEELOS THERAPEUTICS INC PA
SEELQ
Lind Global Fund II LP 44,500
9.900%
44,500increase
(New Position)
Filing